In vitro dose effect relationships of actinium-225- and lutetium-177-labeled PSMA-I&T

PURPOSE: Targeting the prostate-specific membrane antigen (PSMA) using lutetium-177-labeled PSMA-specific tracers has become a very promising novel therapy option for prostate cancer (PCa). The efficacy of this therapy might be further improved by replacing the β-emitting lutetium-177 with the α-emi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruigrok, Eline A. M., Tamborino, Giulia, de Blois, Erik, Roobol, Stefan J., Verkaik, Nicole, De Saint-Hubert, Marijke, Konijnenberg, Mark W., van Weerden, Wytske M., de Jong, Marion, Nonnekens, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399067/
https://www.ncbi.nlm.nih.gov/pubmed/35556158
http://dx.doi.org/10.1007/s00259-022-05821-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399067/
https://www.ncbi.nlm.nih.gov/pubmed/35556158
http://dx.doi.org/10.1007/s00259-022-05821-w

Ejemplares similares